SG Americas Securities LLC increased its position in GSK plc (NYSE:GSK – Free Report) by 167.3% in the third quarter, ...

Macron, a former investment banker dubbed the "Mozart of finance," blew a hole in the country's public finances with a surge in pandemic-related spending; a military buildup and energy subsidies to ...

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

European shares closed lower on Thursday, with defence and industrial stocks leading losses, after data showed U.S. inflation ...

Shares slipped in New York and Europe Thursday as the latest US inflation report strengthened the case for a slower pace of ...

The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the ...

GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer ...

Chinese stock markets returned to winning ways Thursday, closing with solid gains after China's central bank took action to ...

Early fall is when asthma flare-ups peak in the U.S., and a warming climate is bad news for sufferers: It means more ...

GSK’s $2.2 billion Zantac settlement today put its shares top of the FTSE 100, albeit still well short of their level before ...

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...